Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters

被引：0
|
作者：
Mostafa, Hamdy Mahfouz [1 ]
Eid, Khaled Abdel Azeem [1 ]
Maguid, Mona Mohamed Abdel [2 ]
Elsaid, Abdel Rahman Abdel Hamid [2 ]
机构：
[1] Al Azhar Univ, Assiut, Egypt
[2] S Valley Univ, Qena, Egypt
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [41] Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin
    Carriero, D.
    Fabrizi, Fabrizio
    Uriel, A.J.
    Park, J.
    Martin, P.
    Dieterich, D.T.
    International Journal of Artificial Organs, 2008, 31 (04): : 295 - 302
  • [42] Kinetic of Virologic Response to Pegylated Interferon and Ribavirin in Children With Chronic Hepatitis C Predicts the Effect of Treatment
    Indolfi, Giuseppe
    Nebbia, Gabriella
    Cananzi, Mara
    Maccabruni, Anna
    Zaramella, Marco
    D'Antiga, Lorenzo
    Grisotto, Laura
    Azzari, Chiara
    Resti, Massimo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1300 - 1303
  • [43] Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients.
    Hopkins, S
    Hennessy, M
    Lyons, F
    Mulachy, F
    Bergin, C
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [44] THE EFFECT OF INTERFERON AND RIBAVIRIN TREATMENT ON HEARING LEVELS IN PATIENTS WITH CHRONIC HEPATITIS C
    Senol, Altug
    Aksakal, Gokhan
    Akin, Mete
    Yariktas, Murat
    Goren, Ibrahim
    Isler, Mehmet
    NOBEL MEDICUS, 2016, 12 (01): : 35 - 38
  • [45] Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin
    Carriero, D.
    Fabrizi, F.
    Uriel, A. J.
    Park, J.
    Martin, P.
    Dieterich, D. T.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (04): : 295 - 302
  • [46] Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients
    Malekzadeh, R
    Merat, S
    Sohrabpour, AA
    Khaleghi, S
    Samimi-Rad, K
    GASTROENTEROLOGY, 2004, 126 (04) : A431 - A431
  • [47] Effectiveness of Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Urban Minority Patients
    Ridruejo, Ezequiel
    Adrover, Raul
    Cocozzelia, Daniel
    Virgina Reggiardo, Maria
    Fernandez, Nora
    HEPATOLOGY, 2010, 51 (06) : 2231 - 2231
  • [48] Effectiveness of Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Urban Minority Patients
    Feuerstadt, Paul
    Bunim, Ari L.
    Garcia, Heriberto
    Karlitz, Jordan J.
    Massoumi, Hatef
    Thosani, Amar J.
    Pellecchia, Andrew
    Wolkoff, Allan W.
    Gaglio, Paul J.
    Reinus, John F.
    HEPATOLOGY, 2010, 51 (04) : 1137 - 1143
  • [49] Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C
    Kowala-Piaskowska, Arleta
    Mozer-Lisewska, Iwona
    Figlerowicz, Magdalena
    Sluzewski, Wojciech
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) : 1095 - 1103
  • [50] Treatment response of chronic hepatitis C virus infection with pegylated-interferon and ribavirin
    Humphris, J. L.
    Ngu, M. C.
    Lee, A. U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A331 - A331
12345